Treatment of Relapsed Extranodal Natural Killer/T-Cell Lymphoma With Bortezomib Plus Fludarabine

Molecular and Clinical Oncology - United Kingdom
doi 10.3892/mco.2017.1364
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Spandidos Publications

Related search

Clinical Characteristics and Treatment of 69 Patients With Extranodal Natural Killer T-Cell Lymphoma

Molecular and Clinical Oncology
Cancer ResearchOncology
2016English

Extranodal Natural Killer/T-Cell Lymphoma: Current Concepts in Biology and Treatment

Leukemia and Lymphoma
Cancer ResearchOncologyHematology
2009English

Maxillary Sinus Natural Killer/T-Cell Extranodal Lymphoma Mimicking a Dentoalveolar Abscess

Case Reports in Dentistry
Dentistry
2019English

Extranodal Natural Killer/T-Cell Lymphoma, Nasal Type Involving Skin Masquerading as Eczema

Annals of Dermatology
Dermatology
2016English

CD30+ Extranodal Natural Killer/T‑cell Lymphoma Mimicking Phlegmonous Myositis: A Case Report

Oncology Letters
Cancer ResearchOncology
2014English

A Prognostic Nomogram for Overall Survival in Extranodal Natural Killer/T-Cell Lymphoma Patients

Clinical Lymphoma, Myeloma and Leukemia
Cancer ResearchOncologyHematology
2018English

Nasal Natural Killer/T Cell Lymphoma

Indian Journal of Hematology and Blood Transfusion
Hematology
2014English

Extranodal Nasal-Type Natural Killer/T-Cell Lymphoma With Penile Involvement: A Case Report and Review of the Literature

BMC Urology
MedicineReproductive MedicineUrology
2017English

Increased Body Mass Index Is Associated With Improved Overall Survival in Extranodal Natural Killer/T-Cell Lymphoma, Nasal Type

Oncotarget
Oncology
2016English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy